FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765875376> ?p ?o ?g. }

• W2765875376 endingPage "415" @default.
• W2765875376 startingPage "406" @default.
• W2765875376 abstract "Trop2, a transmembrane glycoprotein, has emerged as a biomarker for targeted cancer therapy since it is overexpressed in 80% of triple negative breast cancer (TNBC) patients. For the site-specific delivery of the anticancer drug into TNBC, anti-Trop2 antibody-conjugated nanoparticles (ST-NPs) were prepared as the potential nanocarrier, composed of carboxymethyl dextran (CMD) derivatives with bioreducible disulfide bonds. Owing to its amphiphilicity, the CMD derivatives were self-assembled into nano-sized particles in an aqueous condition. Doxorubicin (DOX), chosen as a model anticancer drug, was effectively encapsulated into the nanoparticles. DOX-loaded ST-NPs (DOX-ST-NPs) rapidly released DOX in the presence of 10mM glutathione (GSH), whereas the DOX release is significantly retarded in the physiological condition (PBS, pH 7.4). Confocal microscopic images and flow cytometry analysis demonstrated that DOX-ST-NPs were selectively taken up by MDA-MB-231 as the representative Trop2-expressing TNBC cells. Consequently, DOX-ST-NPs exhibited higher toxicity to Trop2-positive MDA-MB-231 cancer cells, compared to DOX-loaded control nanoparticles without the disulfide bond or anti-Trop2 antibody. Overall, ST-NPs might be a promising carrier of DOX for targeted TNBC therapy." @default.
• W2765875376 created "2017-11-10" @default.
• W2765875376 creator A5000953547 @default.
• W2765875376 creator A5017792494 @default.
• W2765875376 creator A5030258470 @default.
• W2765875376 creator A5044441372 @default.
• W2765875376 creator A5044491242 @default.
• W2765875376 creator A5049872669 @default.
• W2765875376 creator A5056586797 @default.
• W2765875376 creator A5079257522 @default.
• W2765875376 creator A5088253355 @default.
• W2765875376 creator A5090608920 @default.
• W2765875376 date "2018-04-01" @default.
• W2765875376 modified "2023-10-14" @default.
• W2765875376 title "Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy" @default.
• W2765875376 cites W1486001319 @default.
• W2765875376 cites W1965278354 @default.
• W2765875376 cites W1968035235 @default.
• W2765875376 cites W1976041621 @default.
• W2765875376 cites W1979388199 @default.
• W2765875376 cites W1985241728 @default.
• W2765875376 cites W2000378366 @default.
• W2765875376 cites W2011866590 @default.
• W2765875376 cites W2013300088 @default.
• W2765875376 cites W2024653190 @default.
• W2765875376 cites W2024787650 @default.
• W2765875376 cites W2035869908 @default.
• W2765875376 cites W2040430014 @default.
• W2765875376 cites W2054045589 @default.
• W2765875376 cites W2082412592 @default.
• W2765875376 cites W2083466846 @default.
• W2765875376 cites W2135601011 @default.
• W2765875376 cites W2135967835 @default.
• W2765875376 cites W2137621491 @default.
• W2765875376 cites W2145638787 @default.
• W2765875376 cites W2160419983 @default.
• W2765875376 cites W2188271125 @default.
• W2765875376 cites W2218303215 @default.
• W2765875376 cites W2326697670 @default.
• W2765875376 cites W2327510349 @default.
• W2765875376 cites W2332704855 @default.
• W2765875376 cites W2482685308 @default.
• W2765875376 cites W2553904358 @default.
• W2765875376 doi "https://doi.org/10.1016/j.ijbiomac.2017.10.113" @default.
• W2765875376 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29055700" @default.
• W2765875376 hasPublicationYear "2018" @default.
• W2765875376 type Work @default.
• W2765875376 sameAs 2765875376 @default.
• W2765875376 citedByCount "45" @default.
• W2765875376 countsByYear W27658753762018 @default.
• W2765875376 countsByYear W27658753762019 @default.
• W2765875376 countsByYear W27658753762020 @default.
• W2765875376 countsByYear W27658753762021 @default.
• W2765875376 countsByYear W27658753762022 @default.
• W2765875376 countsByYear W27658753762023 @default.
• W2765875376 crossrefType "journal-article" @default.
• W2765875376 hasAuthorship W2765875376A5000953547 @default.
• W2765875376 hasAuthorship W2765875376A5017792494 @default.
• W2765875376 hasAuthorship W2765875376A5030258470 @default.
• W2765875376 hasAuthorship W2765875376A5044441372 @default.
• W2765875376 hasAuthorship W2765875376A5044491242 @default.
• W2765875376 hasAuthorship W2765875376A5049872669 @default.
• W2765875376 hasAuthorship W2765875376A5056586797 @default.
• W2765875376 hasAuthorship W2765875376A5079257522 @default.
• W2765875376 hasAuthorship W2765875376A5088253355 @default.
• W2765875376 hasAuthorship W2765875376A5090608920 @default.
• W2765875376 hasConcept C112613896 @default.
• W2765875376 hasConcept C121608353 @default.
• W2765875376 hasConcept C126322002 @default.
• W2765875376 hasConcept C126511603 @default.
• W2765875376 hasConcept C141071460 @default.
• W2765875376 hasConcept C153911025 @default.
• W2765875376 hasConcept C159654299 @default.
• W2765875376 hasConcept C178790620 @default.
• W2765875376 hasConcept C18150654 @default.
• W2765875376 hasConcept C185592680 @default.
• W2765875376 hasConcept C203014093 @default.
• W2765875376 hasConcept C2776694085 @default.
• W2765875376 hasConcept C2779820397 @default.
• W2765875376 hasConcept C2780110267 @default.
• W2765875376 hasConcept C2781230642 @default.
• W2765875376 hasConcept C2781303535 @default.
• W2765875376 hasConcept C502942594 @default.
• W2765875376 hasConcept C521977710 @default.
• W2765875376 hasConcept C530470458 @default.
• W2765875376 hasConcept C553184892 @default.
• W2765875376 hasConcept C71924100 @default.
• W2765875376 hasConcept C86803240 @default.
• W2765875376 hasConceptScore W2765875376C112613896 @default.
• W2765875376 hasConceptScore W2765875376C121608353 @default.
• W2765875376 hasConceptScore W2765875376C126322002 @default.
• W2765875376 hasConceptScore W2765875376C126511603 @default.
• W2765875376 hasConceptScore W2765875376C141071460 @default.
• W2765875376 hasConceptScore W2765875376C153911025 @default.
• W2765875376 hasConceptScore W2765875376C159654299 @default.
• W2765875376 hasConceptScore W2765875376C178790620 @default.
• W2765875376 hasConceptScore W2765875376C18150654 @default.
• W2765875376 hasConceptScore W2765875376C185592680 @default.

• next